Paces Ferry Wealth Advisors’s Aimmune Therapeutics AIMT Stock Holding History

Paces Ferry Wealth Advisors’s Portfolio AIMT Stock Details AIMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-17	Closed	-$1K	–	1294
2020 Q3	$1K	Buy	+17	New	+$362	﹤0.01%	1063

Paces Ferry Wealth Advisors's AIMT Position: Q4 2020 in Review

Paces Ferry Wealth Advisors sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 17 shares — an estimated $1K sold.

Paces Ferry Wealth Advisors first reported a position in AIMT in Q3 2020 and held it in 1 quarter. The position peaked at $1K in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

Paces Ferry Wealth Advisors reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
Paces Ferry Wealth Advisors sold 17 Aimmune Therapeutics shares in Q4 2020, an estimated $1K.
Paces Ferry Wealth Advisors first reported a position in Aimmune Therapeutics in Q3 2020 and held it in 1 quarter.
Paces Ferry Wealth Advisors's Aimmune Therapeutics position peaked at $1K in Q3 2020.
0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Paces Ferry Wealth Advisors's 13F filing for Q4 2020, filed 5 Mar 2021.